Figure 4.
A 99Tcm-octreotide scintigraph images from an active TAO patient before and after corticosteroid therapy. (a) 99Tcm-octreotide scintigraph image before (left image) and after treatment (right image). The accumulation of 99Tcm-octreotide in the orbital areas was significantly decreased after therapy. (b) For active TAO patients, the 2-h UR (*) and CAS (#) were both decreased after treatment (*P<0.05, #P<0.05).